Australia’s active vaccine safety system

AusVaxSafety commenced routine safety monitoring of 2026 seasonal influenza vaccines used in Australia across all ages in March 2026.

The influenza vaccines in use in Australia in 2026 are:

Standard inactivated (injectable) influenza vaccines

  • Flucelvax (individuals aged 6 months and older)
  • Fluzone (individuals aged 6 months and older)
  • Influvac (individuals aged 6 months and older)
  • Vaxigrip (individuals aged 6 months and older)

Adjuvanted or high-dose inactivated (injectable) influenza vaccines 

  • Fluad (individuals aged 50 years and older)
  • Fluzone High-Dose (individuals aged 60 years and over)

Intranasal live attenuated (nasal spray) influenza vaccine 

  • FluMist (individuals aged 2 years to less than 18 years)

AusVaxSafety collects vaccine safety data using vaccine safety surveys sent to influenza vaccine recipients in the days following their vaccination.
 


Latest influenza vaccine safety data

Click on the tiles below to view 2026 AusVaxSafety influenza vaccine safety data for specific age and population groups. Note: Additional age, population groups and vaccine types will be added below once enough data are collected for meaningful analysis.